Lisa De Francesco is SVP, IR and Corp Comm of LEXICON PHARMACEUTICALS, INC.. Currently has a direct ownership of 15,577 shares of LXRX, which is worth approximately $8,878. The most recent transaction as insider was on Feb 28, 2025, when has been sold 9,096 shares (Common Stock) at a price of $0.67 per share, resulting in proceeds of $6,094. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 15.6K
n/a 3M change
n/a 12M change
Total Value Held $8,878

Lisa DeFrancesco Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 28 2025
SELL
Payment of exercise price or tax liability
$6,094 $0.67 p/Share
9,096 Reduced 36.87%
15,577 Common Stock
Feb 28 2025
BUY
Exercise of conversion of derivative security
-
24,673 Added 50.0%
24,673 Common Stock

Also insider at

ICPT
INTERCEPT PHARMACEUTICALS, INC. Healthcare
LD

Lisa De Francesco

SVP, IR and Corp Comm
New York, NY

Track Institutional and Insider Activities on LXRX

Follow LEXICON PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LXRX shares.

Notify only if

Insider Trading

Get notified when an Lexicon Pharmaceuticals, Inc. insider buys or sells LXRX shares.

Notify only if

News

Receive news related to LEXICON PHARMACEUTICALS, INC.

Track Activities on LXRX